Human fibrinogen concentrate
PreclinicalSmall molecule
CSL BehringHuman fibrinogen concentrate is one of 3 small molecule programs targeting High Risk Patients. It is currently in Preclinical.
1
Indications
6
Total Trials
0
Active Trials
2
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
3 competitors in High Risk Patients
#DrugCompanyPhaseTrials
1Pentoxiphylline
IInstitute of Liver and Biliary Sciences, India
Preclinical
Human fibrinogen concentrate
CSL BehringPreclinical
Pentoxyphylline
NNational Taiwan University Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Liver1 trial
Fibrinogen in Haemorrhage of Delivery
Completed·LLaboratoire français de Fractionnement et de Biotechnologies·Phase 4·NCT02155725·448 enrolled
1 more indication
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company